<DOC>
	<DOCNO>NCT00894543</DOCNO>
	<brief_summary>The purpose study test whether medication reduces number , severity bothersomeness menopausal hot flash . Escitalopram ( also call Lexapro® ) selective serotonin reuptake inhibitor ( SSRI ) . It sell prescription depression general anxiety disorder . An SSRI increase serotonin , brain substance believe influence mood . Serotonin may also affect brain level estradiol , hormone related hot flash . This research study test whether escitalopram reduces menopausal hot flash .</brief_summary>
	<brief_title>MsFLASH-01 : Escitalopram Menopausal Symptoms Midlife Women</brief_title>
	<detailed_description>The MsFLASH-01 study , Efficacy Selective Serotonin Reuptake Inhibitor ( SSRI ) Menopausal Symptoms Midlife Women randomize , double-blind , placebo-controlled , parallel arm clinical trial . The design include : 3 week daily record hot flash prior drug treatment ; 8 week double-blind treatment escitalopram placebo dose escalation 4 week among non-responders ; 1 week drug taper high dose , follow 2 week treatment ; telephone follow-up post-treatment . This study one five clinical trial conduct part Menopause Strategies - Finding Lasting Answers Symptoms Health ( MsFLASH ) study , network investigator clinical trial design find new way alleviate common , bothersome symptom menopausal transition .</detailed_description>
	<mesh_term>Hot Flashes</mesh_term>
	<mesh_term>Serotonin</mesh_term>
	<mesh_term>Citalopram</mesh_term>
	<mesh_term>Dexetimide</mesh_term>
	<mesh_term>Serotonin Uptake Inhibitors</mesh_term>
	<criteria>Inclusion Criteria , Common MsFLASH Studies : Females age 4062 year . Menopausal , include : Women uterus skip 2 menstrual cycle amenorrhea interval ≥60 day past 12 month . Women bilateral oophorectomy ( surgical removal ovary ) . Women without uterus still ovaries , certain condition determine screen . Having bothersome hot flash . In general good health determine medical history physical measure . Signed informed consent . Exclusion Criteria , Common MsFLASH Studies : Use hormone therapy hormonal contraceptive 2 month enrollment duration study . Certain exception apply , determine screening . Use therapy take specifically hot flash , include prescription , overthecounter , herbal therapy past month duration study . Any current severe unstable medical illness . Uncontrolled hypertension ( &gt; 160/100 ) rest heart rate &gt; 110 . History endometrial ovarian cancer ; MI , angina , cerebrovascular event . Pregnancy , intend pregnancy , breast feeding . Current participation another drug trial intervention study . Inability unwillingness complete study procedure . Certain condition , determine screening . Exclusion Criteria , Specific MsFLASH01 : Use selective estrogen receptor modulators ( SERMS ) aromatase inhibitor two month enrollment . Use gabapentin , pregabalin , triptans , warfarin ( Coumadin® ) , St. John 's Wort . Known hypersensitivity escitalopram ( Lexapro® ) citalopram ( Celexa® ) . Use antidepressant past 30 day start Study 01 , include SSRIs , serotoninnorepinephrine reuptake inhibitor ( SNRIs ) , monoamine oxidase inhibitor ( MAOIs ) , anxiolytic . Not use medically approve method birth control , sexually active 12 month since last menstrual period . History liver , gall bladder , renal disease , uncontrolled seizure disorder . Certain condition , determine screening .</criteria>
	<gender>Female</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>62 Years</maximum_age>
	<verification_date>March 2013</verification_date>
	<keyword>Hot flash</keyword>
	<keyword>Menopause</keyword>
	<keyword>Vasomotor symptom</keyword>
</DOC>